HLK Biotech Holding Group, Inc.

HLK Biotech Holding Group, Inc.

AMHD
HLK Biotech Holding Group, Inc.US flagOther OTC
0.00
USD
- -
- -
925.00Market Cap
HLK Biotech Holding Group, Inc.
AMHD
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
HLK Biotech Holding Group, Inc. (AMHD) is a holding company that, through its subsidiaries, produces and sells biodiesel; acquires real estate properties; and focuses on research and development of high-tech health foods, healthcare supplies, and low-carbon environmental protection solutions. The company operates primarily through China-based subsidiaries in the health and alternative energy sectors, targeting markets in the United States and Asia with an emphasis on renewable fuels and biotech products. Founded in 1998 and headquartered at 2612 Granby Street in Norfolk, Virginia, it changed its name from Amelot Holdings, Inc. to HLK Biotech Holding Group, Inc. in February 2018, marking a strategic shift toward biotech and sustainability initiatives. No major acquisitions, funding rounds, partnerships, or new product launches have been reported in the last 1-2 years, with the company maintaining a low operational profile amid minimal revenue activity.